In-depth trading ideas

Discover detailed market analysis from traders. See how others approach this instrument, compare different strategies, and discover perspectives that can shape your own view.

Revive Therapetics Canada Sun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series Focus: Worldwide By Sun Storm Investment Research & NexGen Wealth Management Service A Profit & Solutions Strategy & Research Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures | USA | Canada | UK | Germany | France | Italy | Rest of Europe | Mexico | India Disclaimer: Sun Storm Investment and NexGen are not regist

by Sunstorminvest

Not quite Wyckoff accumulation schematic #1 on RVVTF *HELP*I've been following this particular stock since Feb of 2019. I am not very good at technical analysis but I know this stock should double on or before March 2021. With that assumption is their anyone that can chart this stock and come to the same conclusion? Thanks in advance.

by joshuadbryson

RVV long Looking for a run in this tightly wound pattern. Usual 50:50 stop loss mgmt plan

by tradersteve22

RVV Long Simple run back to 382, MA's have flipped. Looking for the bigger rally but may be too early in the large wedge pattern currently playing out. Daily 200 and top trend line may be the death of the trade. Usual stop loss management of move into profit the trail 50:50 weekly and daily.

by tradersteve22

Long on RVVTF I am already in from an earlier stage, but after breaking out of this triangle upwards I see RVVTF going up back to 75 cents around. It broke out of consolidation and came back down to re test, but after breaking past the sturdy resistance it is now on route up!

RVV Breakout Juice

RVV Idea Description on chart, Just thinking out loud. Just my opinion. always DYODD.

Entry_RVV RVV looks like it came down highs before it step functioned to $0.75 then came back to the around $0.50 may be a decent entry when stock price goes below the dotted orange line...

by CrookedTREE_FINTECH

RVV_Long RVV long based on the technicals

by CrookedTREE_FINTECH

RVV.CA: Bullish Pennant, bigger Bullish Pennant Pros: Descending volume during formation 200MA ascending PPS above 50MA and 200MA R/R ratio above 16 250RSI above 50 RS Ascending and above 0 If confirmed: PT = 1.29$

RVV.CA: Bullish Pennant Bullish Pennant Pros: Descending volume during formation 200MA ascending PPS above 50MA and 200MA R/R ratio above 4 Cons: 250RSI below 50 If confirmed: PT = 0,58$

Daily oversold bounce For those who had taken profit or still waiting on the sidelines to get back into this bad boy, well here is your chance. We have just hit daily oversold conditions into an area of support and the rsi as crossed the 30 line. indicating a signal to go long. on the 65 minute timeframe we can also see a lot of bullish divergence. 0.240 would be a good target for a scalp , but this also still has potential for it's covid treatment. It's quite a volatile little thing so this isn't for the feint of h

Swing/Long on RVV RVV is picking up some traction, one thing I notice about RVV is that the share price is directly correlated to the MACD indicator. You will see above that if you bought and the cross over to the upside, and sold at the crossover to the downside, you would be doing consistently well. RVV is presently crossing over to the upside, indicators are bullish. Therapeutic stocks (in general) have shown a reversal wick on Thursday the 24th, which were confirmed with a reversal on the 25th. Although t

RVV.C — FDA Phase 3 Clinical Trials Approval for COVID-19 Drug Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19 TORONTO, July 31, 2020 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that the U.S. Food & Drug Administration (“U.S. FDA”) has approved the Company to proceed with a randomized, double-blind

by agstockpicks

U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial UPDATE - Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19 www.globenewswire.com

RVVTF REVIVE THERAPEUTICS LTD upside potential REVIVE THERAPEUTICS has a Market Capitalization of only 27.158M, while the Net Income (FY) reveals a debt, -1.028M. Some analists predict an Average Target Price of 2.36 usd. The indicators are bullish on most timeframes. Still a lot of room to grow, with that huge volume. If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, like others, just leave me a P.M.

Shroom Is the New Weed I've been bullish on psychedelic stocks for a while now and I really like this low hanging fruit here, RVV. Fundamentals are good and it is only a question of time before psychedelic medicine penetrates the healthcare sector with undeniable therapeutic properties. Company also boasts a nice pharma play imo. Technical (*resolution may affect drawings*): Interesting support on Fibonacci arcs . Bullish candles on (A), (B), and (C). (A) failed although it broke a bearish sequence. The stock reache

by Chasseur-Cueilleur

nice bullish play This ticker has hidden bulish and regular bullish divergence on the trend line making this a very bullish set up Target will be at the anchored vwap where bag holders will likely try to dump their shares.